Comparison of Survival and Prognostic Factors in Patients with Gastric Adenocarcinoma in T2 and T3 Original Article377
Total Page:16
File Type:pdf, Size:1020Kb
Jucá Comparison of survival and prognostic factors in patients with gastric adenocarcinoma in T2 and T3 Original Article377 Comparison of survival and prognostic factors in patients with gastric adenocarcinoma in T2 and T3 Comparação da sobrevivência e dos fatores prognósticos em pacientes com adenocarcinoma gástrico T2 e T3 PATRÍCIA CAMPOS JUCÁ – ACBC-RJ1; LAERCIO LOURENÇO – TCBC-SP2; RUBENS KESLEY – TCBC-RJ1; EDUARDO LINHARES RIELLO DE MELLO – TCBC-RJ1; IVANIR MARTINS DE OLIVEIRA 3; JOSÉ HUMBERTO SIMÕES CORREA – TCBC-RJ1 ABSTRACT Objective: To compare the survival and prognosis after surgical treatment of patients with gastric adenocarcinoma which extends to the muscular layer (T2), and patients whose tumor invades the subserosa (T3). Methods: This was a retrospective study of 122 patients with gastric cancer invading the muscularis propria and subserosa, undergoing surgical treatment from January 1997 to December 2008 and followed-up until December 2010. We analyzed demographic, surgical and pathological variables. Results: Of the 122 patients, 22 (18%) were excluded from the final analysis because they showed: positive margin or less than 15 lymph nodes in the surgical specimen, early postoperative mortality and second primary tumors. Among the 100 patients included, 75 had tumors inveding the muscularis propria (T2) and 25 with extension to the subserosa (T3). Overall survival was 83.8%, and 90.6% for T2 and 52.1% or T3. Univariate analysis showed statistical significance in: lymph node metastasis (p = 0.02), tumor size (p = 0.000), tumor pathological stage (p = 0.000), lymph node pathologic stage (p = 0.000) and staging by classification of groups TNM-UICC/AJCC, 2010 (p = 0.000). In multivariate analysis, independent prognostic factors were tumor size and lymph node pathological staging (pN). Conclusion: The lymph node status and tumor size are independent prognostic factors in tumors with invasion of the muscularis propria and in tumors with invasion of subserosa. T2 lesions have smaller size, lower rate of lymph node metastasis and therefore better prognosis than T3. Key words: Prognosis. Neoplasms. Stomach neoplasms. Adenocarcinoma. Survival rate. INTRODUCTION adjacent structures. Surgical treatment remains the only curative treatment modality3,4 and the extent of resection he incidence of gastric cancer (GC) is decreasing depends on pre and intraoperative localization of the tu- Tworldwide since 1950. However, its aggressiveness, mor, the degree of penetration of the tumor in the stomach malignancy and, consequently, its prognosis remains wall, invasion of adjacent organs and lymph node unchanged, representing the second leading cause of cancer metastasis5 ,6. death, with 628,000 (12.1%) deaths per year1. In Brazil, The identification of prognostic factors in GA according to the National Cancer Institute2 (INCA), the is important to establish the staging and determining estimated incidence of GC for the year 2011 pointed to therapeutic strategies. The tumor that invades the mucosa 21,500 new cases of the disease, 13,820 being in men and submucosa layers (T1), independent of lymph node (64.3%) and 7,680 in women (35, 7%), corresponding to status, is classified as early gastric cancer (EGC), with an estimated risk of 14 new cases per 100,000 men and five-year survival of 93.5% of operated patients, 72.8% eight for every 100,000 women, consolidating its position being in those with positive nodes and 95.6% for those as the fifth malignant tumor in incidence, the second of with no lymph node metastases. When the tumor goes the gastrointestinal tract. beyond the submucosal layer and invades the muscularis Gastric adenocarcinoma (GA) is the most propria (T2), it is classified as advanced gastric cancer common histological type (95%), originating in the (AGC), but it is considered an intermediate stage of tu- epithelium of the gastric mucosa and progressively mor progression between the AGC and EGC, with better involving the entire stomach wall to reach the serosa and prognosis and survival in five years7-14. This category (T2), From the PostGraduate Program in Interdisciplinary Surgical Science, Master’s Degree level, Federal University of São Paulo, São Paulo Medical School, São Paulo State – SP, Brazil. 1. Staff Surgeon, National Cancer Institute – INCA, Rio de Janeiro; 2. Associate Professor, Department of Surgery, Federal University of São Paulo; 3. Head, Pathology Service, National Cancer Institute – INCA, Rio de Janeiro. Rev. Col. Bras. Cir. 2012; 39(5): 377-384 Jucá 378 Comparison of survival and prognostic factors in patients with gastric adenocarcinoma in T2 and T3 infrequent, represents 8% to 18% of resected GCs in METHODS Japan13. The TNM classification of the 2010 American We studied 122 patients with GA, with Joint Committee on Cancer (AJCC) establishes criteria for invasion of the muscularis propria (T2) and invasion of staging based on tumor invasion of the gastric wall, lymph subserosa (T3). All patients were treated at the node invasion and distant metastases. Tumors are grouped Department of Abdominopelvic Surgery, Cancer Hos- into categories according to the stomach wall invasion pital I, INCA, between January 1997 and December (T), number of positive lymph nodes (N) and presence of 2008, and followed up until December 2010. The study distant metastases (M). In 1998, the College of American was approved by the Ethics in Research Committee of Pathologists recommended the subclassification of T2 into the National Cancer Institute, registration number 69/ T2a “ invasion of the muscularis propria, and T2b “ 2009, and of the Federal University of São Paulo under invasion of the subserosa, to allow for better prognostic the record 1484/2009. and survival evaluation in these patients15. In the beginning Of the 122 patients, 22 were excluded from the of this study, we used the sixth edition of the classification final analysis: one due to margins compromised by neoplasia TNM-UICC/AJCC16, which defined this subdivision, in the final histopathology (0.8%); four died in the first 30 recommended by the College of American Pathologists postoperative days (3.2%); four had a second primary tu- for T2, however, with no change in the staging of the mor (3.2%); and 13 had fewer than 15 resected lymph groups that include T2 lesions (stages IB, II and IIIA), ie nodes (10.6%). pT2aN0 and pT2bN0 stage I and pT2aN1 and pT2bN1 Of the 100 patients included, 75 had tumors with stage II. Only lymph node commitment determined the invasion of the muscularis propria (T2), and 25, with invasion change of stage16. of subserosa (T3), according to the seventh edition of the In 2010 the seventh edition of the classification TNM-UICC/AJCC, 201017. The radical surgical classification TNM-UICC/AJCC17 was published, which treatment followed the criteria of the Japanese Gastric separated tumors restricted to the muscularis propria Cancer Association (JGCA)5 according to tumor site. A and those invading the subserosa, T2 and T3, subtotal gastrectomy (STG) was performed in tumors of respectively, into different categories and stages. The the distal stomach, and a total gastrectomy (TG) in tumors T2a remains in the T2 category and T2b passes to of the proximal third. Tumors in the middle third underwent category T3. The nodal pathologic stage (pN) was also STG or GT depending on the distance from the proximal modified, N1 comprising one to two lymph nodes, N2 edge of the tumor to the GEJ. three to six, N3a seven to 15 and N3b 16 or more Lymphadenectomy was performed based on the lymph nodes. In staging by groups, categories T2 and location of the tumor in the stomach, including the lymph T3 were separated, T2N0 becoming stage IB, T3N0 nodes of level I and / or II, according to the report of the and T2N1 stage IIA, T3N1 and T2N2 stage IIB, T3N2 surgeon and the criteria of the Japanese classification5, and T2N3 stage IIIA and T3N3 stage IIIB. This current being considered adequate the sampling of at least 15 classification excludes tumors of the esophagogastric resected lymph nodes. The resection was considered curative junction (EGJ) or that originate in the stomach less (R0) in the absence of macroscopic or microscopic residual than 5cm to the EGJ and invade it. These tumors, of tumor, with margins, proximal and distal, free of neoplasia poor prognosis, are now staged as esophageal at pathology exam during surgery, and in the absence of adenocarcinomas17. This separation of T2 and T3 in distant disease6. different groups of patients confirms that T2 GC has a The demographic variables studied were age and different prognosis from T3. The identification of gender. Patients were divided into two age groups, with prognostic factors related to T2 is important because, 60 years or less and more than 60 years, determined by in this intermediate stage, the cancer may be curable the median and average age. with an appropriate surgical procedure that includes Variables included the type of surgical D2 lymphadenectomy. gastrectomy, total or subtotal, and the extent of There are few published studies evaluating lymphadenectomy performed, level 1 (D1) and level 1 and the prognostic factors in patients with T28,10,13,14. 2 (D2), described by the surgeon. Several studies suggest a favorable prognosis for The macroscopic pathologic variables analyzed survival with T2 in five years, close to T18,18-21. Other according to the mean and median found were tumor size series report that the subclassification of T2 (T2/T3) (d” 5 cm or> 5 cm) and the number of lymph nodes resected has no value in the presence of metastatic lymph (d” 33 lymph nodes and> 33 lymph nodes). The macroscopic nodes, since these latter are the determinants of appearance of tumors was analyzed according to the prognosis10,22. classification of Borrmann23 for AGC, including the zero This study aims to compare survival and prognosis category according to the Japanese classification for EGC of patients with T2 and T3 gastric adenocarcinoma after (JGCA)5, when the macroscopic appearance of tumors surgical treatment.